EFOI
Energy Focus, Inc.
There isn't enough reported data to score EFOI yet.
NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
EFOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Healthy | |
| Unavailable |
EFOI's revenue and cash flow are currently healthy, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
EFOI PE Valuation
EFOI has no meaningful PE right now: it lost money over the past year.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
EFOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect EFOI's losses to grow, with revenue growing.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
EFOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.14 | +$0.03 |
| Q2 2026 | -$0.25 | -$0.05 |
| Q1 2026 | -$0.15 | +$0.13 |
| Q4 2025 | -$0.18 | +$0.14 |
| Q3 2025 | -$0.17 | +$0.65 |
| Q2 2025 | -$0.20 | +$0.83 |
| Q1 2025 | -$0.28 | +$1.05 |
| Q4 2024 | -$0.32 | +$1.48 |
EFOI is still losing money, but far less than before: $0.14 per share over the past year, against $21.35 at its worst in late 2019.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
EFOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.8M | +481% |
| Q2 2026 | $3.7M | +228% |
| Q1 2026 | $949K | +54% |
| Q4 2025 | $975K | -24% |
| Q3 2025 | $826K | -31% |
| Q2 2025 | $1.1M | -26% |
| Q1 2025 | $616K | -26% |
| Q4 2024 | $1.3M | -47% |
EFOI's revenue is recovering but still below its 2020 peak: $5M last quarter, up 481% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +32 points |
| Q2 2026 | -23% | -3.5 points |
| Q1 2026 | -15% | +29 points |
| Q4 2025 | -37% | -14 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -20% | +16 points |
| Q1 2025 | -44% | +28 points |
| Q4 2024 | -23% | +9.4 points |
EFOI has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over EFOI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
EFOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.2M | +$2.3M |
| Q2 2026 | -$819K | -$604K |
| Q1 2026 | $69K | +$346K |
| Q4 2025 | -$862K | -$608K |
| Q3 2025 | -$104K | +$182K |
| Q2 2025 | -$215K | +$503K |
| Q1 2025 | -$277K | -$219K |
| Q4 2024 | -$254K | -$143K |
EFOI's free cash flow has turned positive after six years mostly in the red: $629,000 over the past year.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
EFOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +67K shares |
| 1 year | +14% | +784K shares |
| 3 years | +131% | +3.6M shares |
| 5 years | +963% | +5.8M shares |
| Available history | +1350% | +6M shares |
EFOI has 6M diluted shares, up 14% from a year ago.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has the edge over EFOI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
EFOI Net Leverage
EFOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EFOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.4 | Neutral |
| Stochastic | 76.9 | Neutral |
EFOI's weekly RSI is 68 (neutral) and its Stochastic is 77 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
EFOI PE vs Consumer Cyclical Sector
EFOI has no meaningful PE right now: it lost money over the past year.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
EFOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 34% above |
| 20 week MA | $3.10 | 45% above |
| 50 week MA | $2.90 | 55% above |
| 100 week MA | $2.47 | 82% above |
| 200 week MA | $2.25 | 100% above |
EFOI has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
EFOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.1 | $29.4 | +83% |
| 2021 | $29.4 | $28.1 | -4.3% |
| 2022 | $28.1 | $2.10 | -93% |
| 2023 | $2.10 | $1.51 | -28% |
| 2024 | $1.51 | $1.25 | -17% |
| 2025 | $1.25 | $2.25 | +80% |
| 2026 YTD | $2.25 | $4.50 | +100% |
EFOI has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.